nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—SLC6A4—obesity	0.176	0.501	CbGaD
Vilazodone—DRD2—obesity	0.175	0.499	CbGaD
Vilazodone—SLC6A4—Sibutramine—obesity	0.125	0.279	CbGbCtD
Vilazodone—SLC6A4—Phentermine—obesity	0.0947	0.212	CbGbCtD
Vilazodone—SLC6A4—Methamphetamine—obesity	0.0757	0.169	CbGbCtD
Vilazodone—CYP2D6—Phentermine—obesity	0.0238	0.0531	CbGbCtD
Vilazodone—CYP2D6—Bupropion—obesity	0.0202	0.0452	CbGbCtD
Vilazodone—CYP3A4—Sibutramine—obesity	0.0199	0.0446	CbGbCtD
Vilazodone—CYP2D6—Methamphetamine—obesity	0.019	0.0425	CbGbCtD
Vilazodone—CYP3A4—Benzphetamine—obesity	0.0151	0.0338	CbGbCtD
Vilazodone—CYP2D6—Cimetidine—obesity	0.0148	0.0332	CbGbCtD
Vilazodone—CYP3A4—Bupropion—obesity	0.0128	0.0287	CbGbCtD
Vilazodone—CYP3A4—Orlistat—obesity	0.0105	0.0234	CbGbCtD
Vilazodone—CYP3A4—Cimetidine—obesity	0.00943	0.0211	CbGbCtD
Vilazodone—CYP3A4—Topiramate—obesity	0.00617	0.0138	CbGbCtD
Vilazodone—Agitation—Methamphetamine—obesity	0.000822	0.00652	CcSEcCtD
Vilazodone—Suicidal ideation—Bupropion—obesity	0.000808	0.00641	CcSEcCtD
Vilazodone—Tremor—Benzphetamine—obesity	0.000808	0.00641	CcSEcCtD
Vilazodone—Agitation—Benzphetamine—obesity	0.000793	0.00629	CcSEcCtD
Vilazodone—Palpitations—Methamphetamine—obesity	0.000791	0.00627	CcSEcCtD
Vilazodone—Mania—Bupropion—obesity	0.00078	0.00619	CcSEcCtD
Vilazodone—Hallucination—Phenylpropanolamine—obesity	0.000768	0.00609	CcSEcCtD
Vilazodone—Palpitations—Benzphetamine—obesity	0.000762	0.00605	CcSEcCtD
Vilazodone—Vision blurred—Phendimetrazine—obesity	0.000741	0.00588	CcSEcCtD
Vilazodone—Erectile dysfunction—Diethylpropion—obesity	0.000739	0.00587	CcSEcCtD
Vilazodone—Tremor—Phendimetrazine—obesity	0.000737	0.00585	CcSEcCtD
Vilazodone—Hallucination—Phentermine—obesity	0.000735	0.00583	CcSEcCtD
Vilazodone—Agitation—Phendimetrazine—obesity	0.000723	0.00573	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Sibutramine—obesity	0.00072	0.00571	CcSEcCtD
Vilazodone—Erectile dysfunction—Cimetidine—obesity	0.000703	0.00558	CcSEcCtD
Vilazodone—Suicide—Topiramate—obesity	0.000696	0.00552	CcSEcCtD
Vilazodone—Palpitations—Phendimetrazine—obesity	0.000695	0.00551	CcSEcCtD
Vilazodone—Cataract—Sibutramine—obesity	0.000683	0.00542	CcSEcCtD
Vilazodone—Hyperhidrosis—Benzphetamine—obesity	0.000681	0.0054	CcSEcCtD
Vilazodone—Insomnia—Methamphetamine—obesity	0.00066	0.00524	CcSEcCtD
Vilazodone—Nervousness—Phenylpropanolamine—obesity	0.000652	0.00518	CcSEcCtD
Vilazodone—Sexual dysfunction—Topiramate—obesity	0.000644	0.00511	CcSEcCtD
Vilazodone—Dyspepsia—Methamphetamine—obesity	0.000643	0.0051	CcSEcCtD
Vilazodone—Abnormal dreams—Sibutramine—obesity	0.000643	0.0051	CcSEcCtD
Vilazodone—Insomnia—Benzphetamine—obesity	0.000637	0.00505	CcSEcCtD
Vilazodone—Suicide attempt—Topiramate—obesity	0.000637	0.00505	CcSEcCtD
Vilazodone—Vision blurred—Phenylpropanolamine—obesity	0.000633	0.00502	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Methamphetamine—obesity	0.00063	0.005	CcSEcCtD
Vilazodone—Tremor—Phenylpropanolamine—obesity	0.000629	0.00499	CcSEcCtD
Vilazodone—Nervousness—Phentermine—obesity	0.000624	0.00495	CcSEcCtD
Vilazodone—Hyperhidrosis—Phendimetrazine—obesity	0.00062	0.00492	CcSEcCtD
Vilazodone—Dyspepsia—Benzphetamine—obesity	0.00062	0.00492	CcSEcCtD
Vilazodone—Agitation—Phenylpropanolamine—obesity	0.000617	0.0049	CcSEcCtD
Vilazodone—Completed suicide—Topiramate—obesity	0.000614	0.00487	CcSEcCtD
Vilazodone—Decreased appetite—Benzphetamine—obesity	0.000612	0.00486	CcSEcCtD
Vilazodone—Hallucination—Cimetidine—obesity	0.000608	0.00483	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Benzphetamine—obesity	0.000608	0.00482	CcSEcCtD
Vilazodone—Tremor—Phentermine—obesity	0.000602	0.00478	CcSEcCtD
Vilazodone—Dry eye—Sibutramine—obesity	0.000601	0.00477	CcSEcCtD
Vilazodone—Agitation—Phentermine—obesity	0.000591	0.00469	CcSEcCtD
Vilazodone—Insomnia—Phendimetrazine—obesity	0.00058	0.00461	CcSEcCtD
Vilazodone—Palpitations—Phentermine—obesity	0.000568	0.00451	CcSEcCtD
Vilazodone—Abnormal dreams—Bupropion—obesity	0.00056	0.00445	CcSEcCtD
Vilazodone—Decreased appetite—Phendimetrazine—obesity	0.000558	0.00443	CcSEcCtD
Vilazodone—Nervousness—Diethylpropion—obesity	0.000543	0.00431	CcSEcCtD
Vilazodone—Dry mouth—Phentermine—obesity	0.000535	0.00425	CcSEcCtD
Vilazodone—Gastroenteritis—Sibutramine—obesity	0.000533	0.00423	CcSEcCtD
Vilazodone—Vision blurred—Diethylpropion—obesity	0.000527	0.00418	CcSEcCtD
Vilazodone—Flatulence—Cimetidine—obesity	0.000524	0.00416	CcSEcCtD
Vilazodone—Tremor—Diethylpropion—obesity	0.000524	0.00416	CcSEcCtD
Vilazodone—Dry eye—Bupropion—obesity	0.000524	0.00415	CcSEcCtD
Vilazodone—Increased appetite—Orlistat—obesity	0.000519	0.00412	CcSEcCtD
Vilazodone—Suicidal ideation—Topiramate—obesity	0.000515	0.00409	CcSEcCtD
Vilazodone—Agitation—Diethylpropion—obesity	0.000514	0.00408	CcSEcCtD
Vilazodone—Libido decreased—Sibutramine—obesity	0.000509	0.00404	CcSEcCtD
Vilazodone—Increased appetite—Sibutramine—obesity	0.000502	0.00399	CcSEcCtD
Vilazodone—Diarrhoea—Methamphetamine—obesity	0.0005	0.00396	CcSEcCtD
Vilazodone—Mania—Topiramate—obesity	0.000497	0.00394	CcSEcCtD
Vilazodone—Insomnia—Phenylpropanolamine—obesity	0.000496	0.00393	CcSEcCtD
Vilazodone—Palpitations—Diethylpropion—obesity	0.000494	0.00392	CcSEcCtD
Vilazodone—Agitation—Cimetidine—obesity	0.000489	0.00388	CcSEcCtD
Vilazodone—Somnolence—Phenylpropanolamine—obesity	0.000487	0.00387	CcSEcCtD
Vilazodone—Convulsion—Diethylpropion—obesity	0.000484	0.00384	CcSEcCtD
Vilazodone—Dizziness—Methamphetamine—obesity	0.000483	0.00383	CcSEcCtD
Vilazodone—Diarrhoea—Benzphetamine—obesity	0.000482	0.00382	CcSEcCtD
Vilazodone—Insomnia—Phentermine—obesity	0.000474	0.00376	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Sibutramine—obesity	0.000468	0.00372	CcSEcCtD
Vilazodone—Dizziness—Benzphetamine—obesity	0.000466	0.00369	CcSEcCtD
Vilazodone—Dry mouth—Diethylpropion—obesity	0.000466	0.00369	CcSEcCtD
Vilazodone—Migraine—Sibutramine—obesity	0.000465	0.00369	CcSEcCtD
Vilazodone—Gastroenteritis—Bupropion—obesity	0.000464	0.00368	CcSEcCtD
Vilazodone—Dyspepsia—Phentermine—obesity	0.000462	0.00366	CcSEcCtD
Vilazodone—Arthralgia—Cimetidine—obesity	0.000453	0.00359	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Phentermine—obesity	0.000453	0.00359	CcSEcCtD
Vilazodone—Fatigue—Phentermine—obesity	0.000452	0.00359	CcSEcCtD
Vilazodone—Feeling abnormal—Phenylpropanolamine—obesity	0.000452	0.00358	CcSEcCtD
Vilazodone—SLC6A4—hindbrain—obesity	0.000447	0.105	CbGeAlD
Vilazodone—Libido decreased—Bupropion—obesity	0.000444	0.00352	CcSEcCtD
Vilazodone—Hyperhidrosis—Diethylpropion—obesity	0.000441	0.0035	CcSEcCtD
Vilazodone—Breast disorder—Orlistat—obesity	0.000441	0.0035	CcSEcCtD
Vilazodone—Diarrhoea—Phendimetrazine—obesity	0.000439	0.00348	CcSEcCtD
Vilazodone—Increased appetite—Bupropion—obesity	0.000438	0.00348	CcSEcCtD
Vilazodone—Dizziness—Phendimetrazine—obesity	0.000424	0.00337	CcSEcCtD
Vilazodone—Nausea—Benzphetamine—obesity	0.000418	0.00332	CcSEcCtD
Vilazodone—Aripiprazole—DRD4—obesity	0.000416	0.13	CrCbGaD
Vilazodone—Musculoskeletal discomfort—Diethylpropion—obesity	0.000416	0.0033	CcSEcCtD
Vilazodone—Insomnia—Diethylpropion—obesity	0.000413	0.00328	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Bupropion—obesity	0.000408	0.00324	CcSEcCtD
Vilazodone—Somnolence—Diethylpropion—obesity	0.000406	0.00322	CcSEcCtD
Vilazodone—Migraine—Bupropion—obesity	0.000405	0.00321	CcSEcCtD
Vilazodone—Dyspepsia—Diethylpropion—obesity	0.000402	0.00319	CcSEcCtD
Vilazodone—HTR1A—hindbrain—obesity	0.000397	0.0933	CbGeAlD
Vilazodone—Musculoskeletal discomfort—Cimetidine—obesity	0.000396	0.00314	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Diethylpropion—obesity	0.000394	0.00313	CcSEcCtD
Vilazodone—Irritability—Bupropion—obesity	0.000393	0.00312	CcSEcCtD
Vilazodone—Somnolence—Cimetidine—obesity	0.000386	0.00306	CcSEcCtD
Vilazodone—Nausea—Phendimetrazine—obesity	0.000381	0.00302	CcSEcCtD
Vilazodone—Pollakiuria—Sibutramine—obesity	0.000377	0.00299	CcSEcCtD
Vilazodone—Asthenia—Phentermine—obesity	0.000376	0.00299	CcSEcCtD
Vilazodone—Feeling abnormal—Diethylpropion—obesity	0.000376	0.00298	CcSEcCtD
Vilazodone—Erectile dysfunction—Sibutramine—obesity	0.000376	0.00298	CcSEcCtD
Vilazodone—Fatigue—Cimetidine—obesity	0.000374	0.00297	CcSEcCtD
Vilazodone—Breast disorder—Bupropion—obesity	0.000372	0.00295	CcSEcCtD
Vilazodone—Aripiprazole—HTR1B—obesity	0.000369	0.116	CrCbGaD
Vilazodone—Dizziness—Phenylpropanolamine—obesity	0.000363	0.00288	CcSEcCtD
Vilazodone—Diarrhoea—Phentermine—obesity	0.000359	0.00285	CcSEcCtD
Vilazodone—DRD2—hindbrain—obesity	0.000358	0.0843	CbGeAlD
Vilazodone—Feeling abnormal—Cimetidine—obesity	0.000358	0.00284	CcSEcCtD
Vilazodone—Aripiprazole—DRD1—obesity	0.000352	0.11	CrCbGaD
Vilazodone—Vomiting—Phenylpropanolamine—obesity	0.000349	0.00277	CcSEcCtD
Vilazodone—Dizziness—Phentermine—obesity	0.000347	0.00275	CcSEcCtD
Vilazodone—CYP2C18—digestive system—obesity	0.000338	0.0795	CbGeAlD
Vilazodone—Dry eye—Topiramate—obesity	0.000334	0.00265	CcSEcCtD
Vilazodone—Vomiting—Phentermine—obesity	0.000334	0.00265	CcSEcCtD
Vilazodone—Pollakiuria—Bupropion—obesity	0.000329	0.00261	CcSEcCtD
Vilazodone—Erectile dysfunction—Bupropion—obesity	0.000328	0.0026	CcSEcCtD
Vilazodone—Aripiprazole—ADRB1—obesity	0.000327	0.102	CrCbGaD
Vilazodone—Nausea—Phenylpropanolamine—obesity	0.000326	0.00258	CcSEcCtD
Vilazodone—Diarrhoea—Diethylpropion—obesity	0.000312	0.00248	CcSEcCtD
Vilazodone—Nausea—Phentermine—obesity	0.000312	0.00247	CcSEcCtD
Vilazodone—Asthenia—Cimetidine—obesity	0.000312	0.00247	CcSEcCtD
Vilazodone—Eye disorder—Sibutramine—obesity	0.000305	0.00242	CcSEcCtD
Vilazodone—Dizziness—Diethylpropion—obesity	0.000302	0.00239	CcSEcCtD
Vilazodone—Aripiprazole—HTR2C—obesity	0.000301	0.0943	CrCbGaD
Vilazodone—Trazodone—HTR2C—obesity	0.0003	0.0938	CrCbGaD
Vilazodone—Diarrhoea—Cimetidine—obesity	0.000297	0.00236	CcSEcCtD
Vilazodone—Gastroenteritis—Topiramate—obesity	0.000296	0.00235	CcSEcCtD
Vilazodone—Mental disorder—Orlistat—obesity	0.000296	0.00235	CcSEcCtD
Vilazodone—Malnutrition—Orlistat—obesity	0.000294	0.00233	CcSEcCtD
Vilazodone—Vomiting—Diethylpropion—obesity	0.00029	0.0023	CcSEcCtD
Vilazodone—Flatulence—Orlistat—obesity	0.000289	0.0023	CcSEcCtD
Vilazodone—Dysgeusia—Orlistat—obesity	0.000288	0.00228	CcSEcCtD
Vilazodone—Dizziness—Cimetidine—obesity	0.000287	0.00228	CcSEcCtD
Vilazodone—Malnutrition—Sibutramine—obesity	0.000284	0.00226	CcSEcCtD
Vilazodone—Hallucination—Bupropion—obesity	0.000283	0.00225	CcSEcCtD
Vilazodone—Libido decreased—Topiramate—obesity	0.000283	0.00224	CcSEcCtD
Vilazodone—Flatulence—Sibutramine—obesity	0.00028	0.00222	CcSEcCtD
Vilazodone—Connective tissue disorder—Bupropion—obesity	0.00028	0.00222	CcSEcCtD
Vilazodone—CYP2C18—endocrine gland—obesity	0.000279	0.0657	CbGeAlD
Vilazodone—Increased appetite—Topiramate—obesity	0.000279	0.00221	CcSEcCtD
Vilazodone—Dysgeusia—Sibutramine—obesity	0.000278	0.00221	CcSEcCtD
Vilazodone—Vision blurred—Orlistat—obesity	0.000277	0.0022	CcSEcCtD
Vilazodone—Nervousness—Sibutramine—obesity	0.000276	0.00219	CcSEcCtD
Vilazodone—Vomiting—Cimetidine—obesity	0.000276	0.00219	CcSEcCtD
Vilazodone—SLC6A4—respiratory system—obesity	0.000273	0.0642	CbGeAlD
Vilazodone—Nausea—Diethylpropion—obesity	0.000271	0.00215	CcSEcCtD
Vilazodone—Vision blurred—Sibutramine—obesity	0.000268	0.00213	CcSEcCtD
Vilazodone—Tremor—Sibutramine—obesity	0.000266	0.00211	CcSEcCtD
Vilazodone—Eye disorder—Bupropion—obesity	0.000266	0.00211	CcSEcCtD
Vilazodone—Cardiac disorder—Bupropion—obesity	0.000264	0.0021	CcSEcCtD
Vilazodone—Hyponatraemia—Topiramate—obesity	0.000263	0.00209	CcSEcCtD
Vilazodone—Agitation—Sibutramine—obesity	0.000261	0.00207	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Topiramate—obesity	0.00026	0.00206	CcSEcCtD
Vilazodone—Palpitations—Orlistat—obesity	0.00026	0.00206	CcSEcCtD
Vilazodone—Migraine—Topiramate—obesity	0.000258	0.00205	CcSEcCtD
Vilazodone—Nausea—Cimetidine—obesity	0.000258	0.00205	CcSEcCtD
Vilazodone—Convulsion—Orlistat—obesity	0.000255	0.00202	CcSEcCtD
Vilazodone—CYP2C18—liver—obesity	0.000252	0.0593	CbGeAlD
Vilazodone—Palpitations—Sibutramine—obesity	0.000251	0.00199	CcSEcCtD
Vilazodone—Irritability—Topiramate—obesity	0.00025	0.00199	CcSEcCtD
Vilazodone—Aripiprazole—SLC6A4—obesity	0.000249	0.0781	CrCbGaD
Vilazodone—Mental disorder—Bupropion—obesity	0.000249	0.00198	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000248	0.00197	CcSEcCtD
Vilazodone—Trazodone—SLC6A4—obesity	0.000248	0.0778	CrCbGaD
Vilazodone—Aripiprazole—DRD2—obesity	0.000248	0.0777	CrCbGaD
Vilazodone—Malnutrition—Bupropion—obesity	0.000248	0.00197	CcSEcCtD
Vilazodone—Convulsion—Sibutramine—obesity	0.000246	0.00195	CcSEcCtD
Vilazodone—Dry mouth—Orlistat—obesity	0.000245	0.00194	CcSEcCtD
Vilazodone—Flatulence—Bupropion—obesity	0.000244	0.00194	CcSEcCtD
Vilazodone—Dysgeusia—Bupropion—obesity	0.000243	0.00193	CcSEcCtD
Vilazodone—Arthralgia—Sibutramine—obesity	0.000242	0.00192	CcSEcCtD
Vilazodone—Nervousness—Bupropion—obesity	0.000241	0.00191	CcSEcCtD
Vilazodone—Breast disorder—Topiramate—obesity	0.000237	0.00188	CcSEcCtD
Vilazodone—Dry mouth—Sibutramine—obesity	0.000237	0.00188	CcSEcCtD
Vilazodone—Nervous system disorder—Orlistat—obesity	0.000235	0.00187	CcSEcCtD
Vilazodone—Vision blurred—Bupropion—obesity	0.000234	0.00185	CcSEcCtD
Vilazodone—Skin disorder—Orlistat—obesity	0.000233	0.00185	CcSEcCtD
Vilazodone—Tremor—Bupropion—obesity	0.000232	0.00184	CcSEcCtD
Vilazodone—Hyperhidrosis—Orlistat—obesity	0.000232	0.00184	CcSEcCtD
Vilazodone—Agitation—Bupropion—obesity	0.000228	0.00181	CcSEcCtD
Vilazodone—Skin disorder—Sibutramine—obesity	0.000225	0.00179	CcSEcCtD
Vilazodone—Hyperhidrosis—Sibutramine—obesity	0.000224	0.00178	CcSEcCtD
Vilazodone—Palpitations—Bupropion—obesity	0.000219	0.00174	CcSEcCtD
Vilazodone—DRD2—respiratory system—obesity	0.000219	0.0515	CbGeAlD
Vilazodone—Musculoskeletal discomfort—Orlistat—obesity	0.000218	0.00173	CcSEcCtD
Vilazodone—Insomnia—Orlistat—obesity	0.000217	0.00172	CcSEcCtD
Vilazodone—CYP2D6—hindbrain—obesity	0.000215	0.0507	CbGeAlD
Vilazodone—Paraesthesia—Orlistat—obesity	0.000215	0.00171	CcSEcCtD
Vilazodone—Convulsion—Bupropion—obesity	0.000215	0.0017	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Sibutramine—obesity	0.000211	0.00168	CcSEcCtD
Vilazodone—Dyspepsia—Orlistat—obesity	0.000211	0.00167	CcSEcCtD
Vilazodone—Arthralgia—Bupropion—obesity	0.000211	0.00167	CcSEcCtD
Vilazodone—Insomnia—Sibutramine—obesity	0.00021	0.00167	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00021	0.00166	CcSEcCtD
Vilazodone—Pollakiuria—Topiramate—obesity	0.000209	0.00166	CcSEcCtD
Vilazodone—Erectile dysfunction—Topiramate—obesity	0.000209	0.00166	CcSEcCtD
Vilazodone—Decreased appetite—Orlistat—obesity	0.000208	0.00165	CcSEcCtD
Vilazodone—Paraesthesia—Sibutramine—obesity	0.000208	0.00165	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Orlistat—obesity	0.000207	0.00164	CcSEcCtD
Vilazodone—Fatigue—Orlistat—obesity	0.000207	0.00164	CcSEcCtD
Vilazodone—Dry mouth—Bupropion—obesity	0.000206	0.00164	CcSEcCtD
Vilazodone—Somnolence—Sibutramine—obesity	0.000206	0.00164	CcSEcCtD
Vilazodone—Dyspepsia—Sibutramine—obesity	0.000204	0.00162	CcSEcCtD
Vilazodone—Decreased appetite—Sibutramine—obesity	0.000202	0.0016	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Sibutramine—obesity	0.0002	0.00159	CcSEcCtD
Vilazodone—Nervous system disorder—Bupropion—obesity	0.000198	0.00157	CcSEcCtD
Vilazodone—Feeling abnormal—Orlistat—obesity	0.000198	0.00157	CcSEcCtD
Vilazodone—Skin disorder—Bupropion—obesity	0.000196	0.00156	CcSEcCtD
Vilazodone—Hyperhidrosis—Bupropion—obesity	0.000196	0.00155	CcSEcCtD
Vilazodone—Aripiprazole—HTR2A—obesity	0.000192	0.06	CrCbGaD
Vilazodone—Feeling abnormal—Sibutramine—obesity	0.000191	0.00152	CcSEcCtD
Vilazodone—Trazodone—HTR2A—obesity	0.000191	0.0598	CrCbGaD
Vilazodone—HTR1A—cardiovascular system—obesity	0.000185	0.0436	CbGeAlD
Vilazodone—Musculoskeletal discomfort—Bupropion—obesity	0.000184	0.00146	CcSEcCtD
Vilazodone—Insomnia—Bupropion—obesity	0.000183	0.00145	CcSEcCtD
Vilazodone—Paraesthesia—Bupropion—obesity	0.000182	0.00144	CcSEcCtD
Vilazodone—Hallucination—Topiramate—obesity	0.00018	0.00143	CcSEcCtD
Vilazodone—Somnolence—Bupropion—obesity	0.00018	0.00143	CcSEcCtD
Vilazodone—Connective tissue disorder—Topiramate—obesity	0.000178	0.00141	CcSEcCtD
Vilazodone—Dyspepsia—Bupropion—obesity	0.000178	0.00141	CcSEcCtD
Vilazodone—Decreased appetite—Bupropion—obesity	0.000176	0.0014	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Bupropion—obesity	0.000175	0.00139	CcSEcCtD
Vilazodone—Fatigue—Bupropion—obesity	0.000174	0.00138	CcSEcCtD
Vilazodone—SLC6A4—digestive system—obesity	0.000173	0.0408	CbGeAlD
Vilazodone—Asthenia—Orlistat—obesity	0.000172	0.00136	CcSEcCtD
Vilazodone—Eye disorder—Topiramate—obesity	0.00017	0.00135	CcSEcCtD
Vilazodone—Cardiac disorder—Topiramate—obesity	0.000168	0.00134	CcSEcCtD
Vilazodone—Feeling abnormal—Bupropion—obesity	0.000167	0.00132	CcSEcCtD
Vilazodone—Asthenia—Sibutramine—obesity	0.000166	0.00132	CcSEcCtD
Vilazodone—Diarrhoea—Orlistat—obesity	0.000164	0.0013	CcSEcCtD
Vilazodone—Mental disorder—Topiramate—obesity	0.000159	0.00126	CcSEcCtD
Vilazodone—Diarrhoea—Sibutramine—obesity	0.000159	0.00126	CcSEcCtD
Vilazodone—Dizziness—Orlistat—obesity	0.000159	0.00126	CcSEcCtD
Vilazodone—Malnutrition—Topiramate—obesity	0.000158	0.00125	CcSEcCtD
Vilazodone—Flatulence—Topiramate—obesity	0.000156	0.00123	CcSEcCtD
Vilazodone—Dysgeusia—Topiramate—obesity	0.000155	0.00123	CcSEcCtD
Vilazodone—Dizziness—Sibutramine—obesity	0.000153	0.00122	CcSEcCtD
Vilazodone—Nervousness—Topiramate—obesity	0.000153	0.00122	CcSEcCtD
Vilazodone—Vomiting—Orlistat—obesity	0.000152	0.00121	CcSEcCtD
Vilazodone—Vision blurred—Topiramate—obesity	0.000149	0.00118	CcSEcCtD
Vilazodone—DRD2—pituitary gland—obesity	0.000148	0.0349	CbGeAlD
Vilazodone—Tremor—Topiramate—obesity	0.000148	0.00117	CcSEcCtD
Vilazodone—Vomiting—Sibutramine—obesity	0.000148	0.00117	CcSEcCtD
Vilazodone—HTR1A—adrenal gland—obesity	0.000147	0.0345	CbGeAlD
Vilazodone—Asthenia—Bupropion—obesity	0.000145	0.00115	CcSEcCtD
Vilazodone—Agitation—Topiramate—obesity	0.000145	0.00115	CcSEcCtD
Vilazodone—SLC6A4—endocrine gland—obesity	0.000143	0.0337	CbGeAlD
Vilazodone—Nausea—Orlistat—obesity	0.000142	0.00113	CcSEcCtD
Vilazodone—Palpitations—Topiramate—obesity	0.00014	0.00111	CcSEcCtD
Vilazodone—Diarrhoea—Bupropion—obesity	0.000138	0.0011	CcSEcCtD
Vilazodone—Nausea—Sibutramine—obesity	0.000138	0.00109	CcSEcCtD
Vilazodone—Convulsion—Topiramate—obesity	0.000137	0.00109	CcSEcCtD
Vilazodone—Arthralgia—Topiramate—obesity	0.000134	0.00107	CcSEcCtD
Vilazodone—Dizziness—Bupropion—obesity	0.000134	0.00106	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000133	0.00106	CcSEcCtD
Vilazodone—Dry mouth—Topiramate—obesity	0.000131	0.00104	CcSEcCtD
Vilazodone—Vomiting—Bupropion—obesity	0.000129	0.00102	CcSEcCtD
Vilazodone—HTR1A—endocrine gland—obesity	0.000127	0.0299	CbGeAlD
Vilazodone—Nervous system disorder—Topiramate—obesity	0.000126	0.001	CcSEcCtD
Vilazodone—Skin disorder—Topiramate—obesity	0.000125	0.000993	CcSEcCtD
Vilazodone—Hyperhidrosis—Topiramate—obesity	0.000125	0.000989	CcSEcCtD
Vilazodone—Nausea—Bupropion—obesity	0.00012	0.000953	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Topiramate—obesity	0.000117	0.000932	CcSEcCtD
Vilazodone—Insomnia—Topiramate—obesity	0.000117	0.000925	CcSEcCtD
Vilazodone—Paraesthesia—Topiramate—obesity	0.000116	0.000918	CcSEcCtD
Vilazodone—DRD2—endocrine gland—obesity	0.000115	0.027	CbGeAlD
Vilazodone—Somnolence—Topiramate—obesity	0.000115	0.000909	CcSEcCtD
Vilazodone—Dyspepsia—Topiramate—obesity	0.000113	0.0009	CcSEcCtD
Vilazodone—Decreased appetite—Topiramate—obesity	0.000112	0.000889	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Topiramate—obesity	0.000111	0.000883	CcSEcCtD
Vilazodone—Fatigue—Topiramate—obesity	0.000111	0.000882	CcSEcCtD
Vilazodone—Feeling abnormal—Topiramate—obesity	0.000106	0.000843	CcSEcCtD
Vilazodone—Asthenia—Topiramate—obesity	9.25e-05	0.000734	CcSEcCtD
Vilazodone—Diarrhoea—Topiramate—obesity	8.82e-05	0.0007	CcSEcCtD
Vilazodone—Dizziness—Topiramate—obesity	8.52e-05	0.000676	CcSEcCtD
Vilazodone—CYP3A4—digestive system—obesity	8.5e-05	0.02	CbGeAlD
Vilazodone—CYP2D6—digestive system—obesity	8.36e-05	0.0197	CbGeAlD
Vilazodone—Vomiting—Topiramate—obesity	8.19e-05	0.00065	CcSEcCtD
Vilazodone—Nausea—Topiramate—obesity	7.65e-05	0.000607	CcSEcCtD
Vilazodone—CYP3A4—endocrine gland—obesity	7.02e-05	0.0165	CbGeAlD
Vilazodone—CYP2D6—endocrine gland—obesity	6.91e-05	0.0163	CbGeAlD
Vilazodone—CYP3A4—liver—obesity	6.33e-05	0.0149	CbGeAlD
Vilazodone—CYP2D6—liver—obesity	6.23e-05	0.0147	CbGeAlD
Vilazodone—HTR1A—Signaling Pathways—GNAS—obesity	6.4e-06	9.34e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRL—obesity	6.39e-06	9.32e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARD—obesity	6.39e-06	9.31e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PRKAR2B—obesity	6.39e-06	9.31e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3R1—obesity	6.37e-06	9.28e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—DCN—obesity	6.34e-06	9.24e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—STK11—obesity	6.3e-06	9.19e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOB—obesity	6.27e-06	9.14e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CCL2—obesity	6.27e-06	9.14e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC27A1—obesity	6.26e-06	9.12e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PLG—obesity	6.23e-06	9.08e-05	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CB—obesity	6.22e-06	9.07e-05	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—RHOA—obesity	6.22e-06	9.07e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CPT1A—obesity	6.17e-06	8.99e-05	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTGS2—obesity	6.17e-06	8.99e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT2—obesity	6.16e-06	8.98e-05	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3R1—obesity	6.15e-06	8.97e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GLUL—obesity	6.14e-06	8.95e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—FABP4—obesity	6.14e-06	8.95e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCL5—obesity	6.12e-06	8.93e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FOXO3—obesity	6.08e-06	8.86e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRB2—obesity	6.06e-06	8.84e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NAMPT—obesity	6.05e-06	8.82e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—LIPC—obesity	6.01e-06	8.76e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GCK—obesity	6.01e-06	8.76e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LPL—obesity	5.99e-06	8.73e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOC3—obesity	5.97e-06	8.71e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SOCS1—obesity	5.97e-06	8.71e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FOXO1—obesity	5.95e-06	8.67e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RPS6KB1—obesity	5.93e-06	8.65e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CD—obesity	5.92e-06	8.63e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SOCS3—obesity	5.9e-06	8.6e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CB—obesity	5.88e-06	8.57e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ECHS1—obesity	5.82e-06	8.48e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—UCP2—obesity	5.82e-06	8.48e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HSD11B1—obesity	5.82e-06	8.48e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—UCP3—obesity	5.82e-06	8.48e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CETP—obesity	5.8e-06	8.45e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GNB3—obesity	5.78e-06	8.42e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SDC1—obesity	5.73e-06	8.36e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ADH1B—obesity	5.72e-06	8.34e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—TYK2—obesity	5.69e-06	8.3e-05	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CB—obesity	5.68e-06	8.28e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF2—obesity	5.67e-06	8.27e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—RHOA—obesity	5.65e-06	8.23e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKR1C3—obesity	5.64e-06	8.22e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARGC1B—obesity	5.63e-06	8.22e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ACSL1—obesity	5.63e-06	8.22e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GPAM—obesity	5.63e-06	8.22e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GNAS—obesity	5.62e-06	8.2e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3R1—obesity	5.59e-06	8.15e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SCARB1—obesity	5.55e-06	8.1e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKCD—obesity	5.52e-06	8.04e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOB—obesity	5.51e-06	8.03e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PCK1—obesity	5.47e-06	7.98e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HADH—obesity	5.47e-06	7.98e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—FADS1—obesity	5.47e-06	7.98e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2A—obesity	5.4e-06	7.87e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—C3—obesity	5.39e-06	7.86e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SREBF1—obesity	5.39e-06	7.86e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCL5—obesity	5.38e-06	7.84e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ACP5—obesity	5.32e-06	7.76e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LPL—obesity	5.26e-06	7.67e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GOT2—obesity	5.24e-06	7.65e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FOXO1—obesity	5.22e-06	7.61e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RPS6KB1—obesity	5.21e-06	7.6e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—G6PD—obesity	5.19e-06	7.56e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CB—obesity	5.16e-06	7.52e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—FASN—obesity	5.13e-06	7.48e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IRS2—obesity	5.13e-06	7.48e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AGT—obesity	5.12e-06	7.47e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HK1—obesity	5.12e-06	7.47e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SREBF2—obesity	5.12e-06	7.47e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—BCHE—obesity	5.11e-06	7.45e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOE—obesity	5.02e-06	7.32e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LEP—obesity	5.02e-06	7.32e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CAV1—obesity	4.97e-06	7.25e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOA1—obesity	4.96e-06	7.23e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LPA—obesity	4.95e-06	7.21e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP2E1—obesity	4.93e-06	7.19e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NQO1—obesity	4.88e-06	7.11e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCD—obesity	4.84e-06	7.06e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LPIN1—obesity	4.84e-06	7.06e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ESR1—obesity	4.79e-06	6.99e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOA5—obesity	4.74e-06	6.91e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2A—obesity	4.74e-06	6.91e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—C3—obesity	4.73e-06	6.9e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKCB—obesity	4.73e-06	6.9e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—F2—obesity	4.73e-06	6.9e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—BAD—obesity	4.68e-06	6.82e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GCG—obesity	4.67e-06	6.82e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SLC2A4—obesity	4.67e-06	6.82e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYCS—obesity	4.61e-06	6.73e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CG—obesity	4.53e-06	6.61e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GOT1—obesity	4.53e-06	6.6e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GGT1—obesity	4.53e-06	6.6e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC22A1—obesity	4.52e-06	6.6e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CLOCK—obesity	4.52e-06	6.6e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IRS2—obesity	4.5e-06	6.57e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AGT—obesity	4.5e-06	6.56e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IRS1—obesity	4.48e-06	6.53e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NCOA1—obesity	4.46e-06	6.5e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GLP1R—obesity	4.41e-06	6.43e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SULT2A1—obesity	4.41e-06	6.43e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LEP—obesity	4.41e-06	6.43e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOE—obesity	4.41e-06	6.43e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP19A1—obesity	4.39e-06	6.41e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—STK11—obesity	4.39e-06	6.41e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CAV1—obesity	4.37e-06	6.37e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOA1—obesity	4.36e-06	6.35e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DPYD—obesity	4.34e-06	6.32e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—POMC—obesity	4.31e-06	6.29e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—INS—obesity	4.29e-06	6.25e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCL2—obesity	4.22e-06	6.15e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ESR1—obesity	4.21e-06	6.13e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PRKAR2B—obesity	4.18e-06	6.09e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—F2—obesity	4.16e-06	6.06e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCB—obesity	4.16e-06	6.06e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF1—obesity	4.15e-06	6.05e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DCN—obesity	4.15e-06	6.04e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT2—obesity	4.14e-06	6.04e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BAD—obesity	4.11e-06	5.99e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—COMT—obesity	4.09e-06	5.96e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CPT1A—obesity	4.03e-06	5.88e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GNB3—obesity	4.03e-06	5.87e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARGC1A—obesity	4.03e-06	5.87e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HMOX1—obesity	4.01e-06	5.85e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CD—obesity	3.98e-06	5.81e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CG—obesity	3.98e-06	5.8e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NAMPT—obesity	3.95e-06	5.77e-05	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CA—obesity	3.94e-06	5.75e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SERPINE1—obesity	3.94e-06	5.74e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IRS1—obesity	3.93e-06	5.73e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LIPC—obesity	3.93e-06	5.73e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GCK—obesity	3.93e-06	5.73e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GNAS—obesity	3.92e-06	5.72e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOC3—obesity	3.91e-06	5.69e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOB—obesity	3.84e-06	5.6e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TYK2—obesity	3.83e-06	5.59e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RHOA—obesity	3.8e-06	5.54e-05	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CA—obesity	3.79e-06	5.53e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CETP—obesity	3.79e-06	5.53e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—POMC—obesity	3.79e-06	5.52e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—INS—obesity	3.77e-06	5.49e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3R1—obesity	3.76e-06	5.48e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOS3—obesity	3.76e-06	5.48e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SDC1—obesity	3.75e-06	5.47e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCL2—obesity	3.7e-06	5.4e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKR1C3—obesity	3.69e-06	5.38e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—LPL—obesity	3.67e-06	5.35e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF1—obesity	3.64e-06	5.31e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT2—obesity	3.64e-06	5.31e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SCARB1—obesity	3.63e-06	5.29e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CA—obesity	3.58e-06	5.22e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GPX1—obesity	3.58e-06	5.22e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SREBF1—obesity	3.52e-06	5.14e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CD—obesity	3.5e-06	5.1e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CD36—obesity	3.49e-06	5.08e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MTOR—obesity	3.47e-06	5.06e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CB—obesity	3.47e-06	5.06e-05	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CA—obesity	3.46e-06	5.05e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SERPINE1—obesity	3.46e-06	5.04e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GOT2—obesity	3.43e-06	5e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TYK2—obesity	3.36e-06	4.9e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—FASN—obesity	3.36e-06	4.89e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—BCHE—obesity	3.34e-06	4.87e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RHOA—obesity	3.34e-06	4.86e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—obesity	3.3e-06	4.82e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3R1—obesity	3.3e-06	4.81e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOS3—obesity	3.3e-06	4.81e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARA—obesity	3.24e-06	4.72e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP2E1—obesity	3.22e-06	4.7e-05	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AKT1—obesity	3.22e-06	4.7e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NQO1—obesity	3.19e-06	4.65e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6—obesity	3.17e-06	4.62e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CA—obesity	3.15e-06	4.59e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AGT—obesity	3.14e-06	4.58e-05	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AKT1—obesity	3.1e-06	4.52e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOE—obesity	3.07e-06	4.48e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GCG—obesity	3.06e-06	4.46e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC2A4—obesity	3.06e-06	4.46e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MTOR—obesity	3.05e-06	4.44e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CB—obesity	3.05e-06	4.44e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CAV1—obesity	3.05e-06	4.44e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOA1—obesity	3.04e-06	4.43e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MMP9—obesity	3.02e-06	4.4e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYCS—obesity	3.02e-06	4.4e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GOT1—obesity	2.96e-06	4.32e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GGT1—obesity	2.96e-06	4.32e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK8—obesity	2.93e-06	4.28e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AKT1—obesity	2.93e-06	4.27e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NCOA1—obesity	2.92e-06	4.25e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—STK11—obesity	2.87e-06	4.19e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP19A1—obesity	2.87e-06	4.19e-05	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AKT1—obesity	2.83e-06	4.13e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6—obesity	2.79e-06	4.06e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CG—obesity	2.77e-06	4.05e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—STAT3—obesity	2.68e-06	3.91e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARG—obesity	2.68e-06	3.9e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—COMT—obesity	2.67e-06	3.89e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MMP9—obesity	2.65e-06	3.86e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—POMC—obesity	2.64e-06	3.85e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARGC1A—obesity	2.63e-06	3.84e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GNB3—obesity	2.63e-06	3.84e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—INS—obesity	2.63e-06	3.83e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HMOX1—obesity	2.62e-06	3.82e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK8—obesity	2.58e-06	3.76e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT1—obesity	2.57e-06	3.75e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GNAS—obesity	2.56e-06	3.74e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOB—obesity	2.51e-06	3.66e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MYC—obesity	2.49e-06	3.63e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TGFB1—obesity	2.49e-06	3.63e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CD—obesity	2.44e-06	3.56e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALB—obesity	2.41e-06	3.51e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LPL—obesity	2.4e-06	3.5e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—STAT3—obesity	2.36e-06	3.43e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GPX1—obesity	2.34e-06	3.41e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NOS3—obesity	2.3e-06	3.36e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3R1—obesity	2.3e-06	3.36e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CD36—obesity	2.28e-06	3.32e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MYC—obesity	2.19e-06	3.19e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TGFB1—obesity	2.18e-06	3.18e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—obesity	2.16e-06	3.15e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CB—obesity	2.13e-06	3.1e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARA—obesity	2.12e-06	3.09e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CA—obesity	2.12e-06	3.09e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTGS2—obesity	2.11e-06	3.07e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AGT—obesity	2.05e-06	2.99e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOE—obesity	2.01e-06	2.93e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CAV1—obesity	1.99e-06	2.9e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOA1—obesity	1.99e-06	2.9e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6—obesity	1.87e-06	2.73e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CA—obesity	1.86e-06	2.71e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CG—obesity	1.81e-06	2.65e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARG—obesity	1.75e-06	2.55e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT1—obesity	1.73e-06	2.52e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—POMC—obesity	1.73e-06	2.52e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—INS—obesity	1.72e-06	2.5e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6—obesity	1.65e-06	2.4e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CD—obesity	1.59e-06	2.33e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALB—obesity	1.57e-06	2.3e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT1—obesity	1.52e-06	2.21e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NOS3—obesity	1.51e-06	2.2e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3R1—obesity	1.51e-06	2.2e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CB—obesity	1.39e-06	2.03e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTGS2—obesity	1.38e-06	2.01e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CA—obesity	1.3e-06	1.89e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKT1—obesity	1.06e-06	1.54e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CA—obesity	8.47e-07	1.24e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKT1—obesity	6.92e-07	1.01e-05	CbGpPWpGaD
